Follow
Mark M Bailey, PhD
Mark M Bailey, PhD
National Intelligence University (NIU)
Verified email at mail.mil
Title
Cited by
Cited by
Year
Nanoparticle formulations in pulmonary drug delivery
MM Bailey, CJ Berkland
Medicinal research reviews 29 (1), 196-212, 2009
3632009
A comparison of human umbilical cord matrix stem cells and temporomandibular joint condylar chondrocytes for tissue engineering temporomandibular joint condylar cartilage
MM Bailey, L Wang, CJ Bode, KE Mitchell, MS Detamore
Tissue engineering 13 (8), 2003-2010, 2007
2072007
Pure insulin nanoparticle agglomerates for pulmonary delivery
MM Bailey, EM Gorman, EJ Munson, C Berkland
Langmuir 24 (23), 13614-13620, 2008
682008
Nanocluster compositions and methods
CJ Berkland, L Shi, N El Gendy, C Plumley, M Bailey
US Patent 8,906,392, 2014
552014
Fluorinated copolymer nanoparticles for multimodal imaging applications
MM Bailey, CM Mahoney, KE Dempah, JM Davis, ML Becker, S Khondee, ...
Macromolecular rapid communications 31 (1), 87-92, 2010
222010
Functionalized, carbon nanotube material for the catalytic degradation of organophosphate nerve agents
MM Bailey, JM Heddleston, J Davis, JL Staymates, AR Hight Walker
Nano Research 7, 390-398, 2014
202014
Particle engineering technologies for pulmonary drug delivery
N El-Gendy, MM Bailey, C Berkland
Controlled pulmonary drug delivery, 283-312, 2011
142011
Fluorinated polymers and associated methods
C Berkland, M Bailey
US Patent App. 12/883,943, 2011
132011
Formulation and Characterization of NanoCluster Ceftazidime for the Treatment of Acute Pulmonary Melioidosis
S Ruiz, N El-Gendy, L Bowen, C Berkland, M Bailey
Respiratory Drug Delivery 2016 Meeting, 2016
102016
Chemically modifiable fluorinated copolymer nanoparticles for 19F‐MRI contrast enhancement
MM Bailey, SR Kline, MD Anderson, JL Staymates, C Berkland
Journal of applied polymer science 126 (4), 1218-1227, 2012
102012
Pulmonary delivery of ceftazidime for the treatment of melioidosis in a murine model
SI Ruiz, LE Bowen, MM Bailey, C Berkland
Molecular pharmaceutics 15 (3), 1371-1376, 2018
62018
Examining the differential risk from high-level artificial intelligence and the question of control
KA Kilian, CJ Ventura, MM Bailey
Futures 151, 103182, 2023
52023
An International Consortium for Evaluations of Societal-Scale Risks from Advanced AI
R Gruetzemacher, A Chan, K Frazier, C Manning, Š Los, J Fox, ...
arXiv preprint arXiv:2310.14455, 2023
22023
A hypergraph-based machine learning ensemble network intrusion detection system
ZZ Lin, TD Pike, MM Bailey, ND Bastian
arXiv preprint arXiv:2211.03933, 2022
22022
PERSPECTIVE: Why Strong Artificial Intelligence Weapons Should Be Considered WMD
M Bailey
https://www.hstoday.us/subject-matter-areas/infrastructure-security …, 2021
22021
Detecting Propagators of Disinformation on Twitter Using Quantitative Discursive Analysis
MM Bailey
Journal of Intelligence Community Research and Development 1 (3), 2020
22020
Development and characterization of an oro-nasal inhalation plethysmography mask exposure system
LE Bowen, MM Bailey, BR Haupt, JB Anderson
Aerosol Science and Technology 51 (4), 509-517, 2017
12017
15 Modified Release Delivery Systems
MM Bailey, CJ Berkland
Biodrug Delivery Systems: Fundamentals, Applications and Clinical …, 2016
1*2016
The Necessity of AI Audit Standards Boards
D Manheim, S Martin, M Bailey, M Samin, R Greutzmacher
arXiv preprint arXiv:2404.13060, 2024
2024
RESEARCH SHORT
MM Bailey
2023
The system can't perform the operation now. Try again later.
Articles 1–20